Theophylline Tablet, Extended Release
Product Images NDC 70771-1783

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 70771-1783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Theophylline Extended-release Tablets 300mg (86fdabb8 C881 4695 8127 59b26998e365 01)

Label for Theophylline Extended-Release Tablets 300 mg oral dosage form. The label indicates a package containing 100 tablets, marked Rx only, manufactured by Zydus Lifesciences Ltd., Ahmedabad, India. Storage and child-resistance information is included, along with the barcode and manufacturer details.*

FDA Label Image

Theophylline Extended-release Tablets 450 mg (86fdabb8 C881 4695 8127 59b26998e365 02)

Theophylline Extended-Release Tablets 450 mg, oral dosage form, packaged in a bottle containing 100 tablets. The label notes the product is for prescription use only, manufactured by Zydus Lifesciences Limited, Ahmedabad, India. Storage instructions and child-resistant packaging information are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.